Details checkedStrong evidenceCheckedcompany

Paradromics Connexus BCI

Also known as: Connexus BCI, Connexus Direct Data Interface, Connect-One Clinical Study, Paradromics Connexus

Paradromics

Primary source

Company

Paradromics

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Fully implantable intracortical BCI with external AI decoding and communication software

Confidence

89%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

United States

Population

adult, implantable-bci, intracortical-interface, speech-restoration, communication-accessibility, investigational-device

Trial IDs

Mechanism

High-bandwidth fully implantable brain-computer interface designed to record neural activity from speech-motor cortex and translate intended communication into text, synthesized speech, or computer-control commands.

Indications

Communication Impairment Severe Paralysis ALS Speech Impairment

Notes

Speech-restoration BCI record rather than a hearing-loss treatment. Included because Connexus is one of the clearest current industry products explicitly targeting restored communication through neural decoding.

Evidence & Sources

3 structured sources

company

Supports: canonicalName, company, mechanism, status, route, populationTags

Open

company

Supports: indications, stage, route

Open

company

Supports: status, keyEvents, geography

Open

Key Events